The Study
Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice
This study didn't test people—it tested mice that were genetically changed to act a little like Alzheimer’s. It showed that when scientists made a specific brain molecule more active, the mice had worse memory and lost some brain connections. But that doesn't mean the same thing happens in people.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
In mice with Alzheimer’s-like brain changes, too much of a brain signal called A2AR makes memory worse—even if plaque levels don’t change. It breaks brain connections and hurts energy production in nerve cells.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 519 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this suggests blocking A2AR (like caffeine does) could protect brain connections and memory in early Alzheimer’s, even before plaques get worse.
- 2Mice with extra A2AR had 34% more tau near plaques, lost key synaptic proteins (GluR2, NR1, Shank3), and showed reduced mitochondrial function—all without more plaques or microglia eating synapses.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Brain
Year
2024
Authors
Victoria Gomez-Murcia, Agathe Launay, Kevin Carvalho, Anaëlle Burgard, C. Mériaux, R. Caillierez, S. Eddarkaoui, Devrim Kilinc, Dolores Siedlecki-Wullich, Mélanie Besegher, S. Bégard, Bryan Thiroux, Matthieu Jung, Ouada Nebie, M. Wisztorski, N. Déglon, Claire Montmasson, A. Bemelmans, M. Hamdane, T. Lebouvier, Didier Vieau, I. Fournier, Luc Buée, S. Lévi, Luísa V. Lopes, A. Boutillier, E. Faivre, David Blum
Related Content
Claims (5)
In a mouse model of early Alzheimer's-like brain changes, increasing adenosine A2A receptors in hippocampal neurons worsens spatial memory deficits without changing amyloid plaque levels, and is linked to higher phosphorylated tau, reduced excitatory synapses, damaged mitochondria, and increased neuroinflammation.
Overexpressing the A2A receptor in neurons of APP/PS1 mice reduces the activity of mitochondrial proteins and genes responsible for energy production, resulting in decreased synaptic function.
In APP/PS1 mice, increasing the number of A2A receptors on neurons reduces key proteins and structures that support excitatory synapses, while leaving inhibitory synapses unchanged.
In mice genetically engineered to develop Alzheimer’s-like brain changes, increasing A2A receptor activity in neurons leads to more phosphorylated tau protein accumulating around amyloid plaques, while the amount of amyloid plaques and total Aβ protein remains unchanged.
In APP/PS1 mice, increased levels of A2A receptors on neurons lead to higher expression of neuroinflammatory genes and greater activation of microglia, and this effect happens without microglia consuming synapses or using C1q-dependent pathways.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.